Infinity Market Research
Infinity Market Research

Global Haemophilus Parasuis Bivalent Vaccine Market Growth, Trends and Opportunities 2025-31


Jan 2026

Healthcare

Pages: 130

LPI50389

PDF Available
Word Available
Excel Available


The global Haemophilus Parasuis Bivalent Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Explore this report in detail? Download a free sample copy

Download Free Sample Report


Haemophilus parasuis disease, also known as Grazers disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.


United States market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


China market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Europe market for Haemophilus Parasuis Bivalent Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Global key Haemophilus Parasuis Bivalent Vaccine players cover Zoetis, Boehringer-Ingelheim, Eurovet, Hipra, Nisseiken, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.


Infinity Market Research newest research report, the Haemophilus Parasuis Bivalent Vaccine Industry Forecast looks at past sales and reviews total world Haemophilus Parasuis Bivalent Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Haemophilus Parasuis Bivalent Vaccine sales for 2025 through 2031. With Haemophilus Parasuis Bivalent Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Haemophilus Parasuis Bivalent Vaccine industry.


This Insight Report provides a comprehensive analysis of the global Haemophilus Parasuis Bivalent Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Haemophilus Parasuis Bivalent Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Haemophilus Parasuis Bivalent Vaccine market.


This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Haemophilus Parasuis Bivalent Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Haemophilus Parasuis Bivalent Vaccine.


This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilus Parasuis Bivalent Vaccine market by product type, application, key manufacturers and key regions and countries.


Segmentation by Type:


    Bivalent Inactivated Vaccine
    Trivalent Inactivated Vaccine
    Quadrivalent Inactivated Vaccine


Segmentation by Application:


    Piglets
    Adults Pigs


This report also splits the market by region:


    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries


The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.


    Zoetis
    Boehringer-Ingelheim
    Eurovet
    Hipra
    Nisseiken
    Merck Animal Health
    SPAH
    Pulike Biological Engineering
    China Animal Husbandry Industry
    Wuhan Keqian Biology
    Wo Hua Biotech
    Zhejiang Ceva Ebvac Biotech
    Luoyang Huizhong Biotech
    Beijing Centrebio Biology
    Shandong Huahong Bioengineering
    Ringpu


Key Questions Addressed in this Report


What is the 10-year outlook for the global Haemophilus Parasuis Bivalent Vaccine market?
What factors are driving Haemophilus Parasuis Bivalent Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Haemophilus Parasuis Bivalent Vaccine market opportunities vary by end market size?
How does Haemophilus Parasuis Bivalent Vaccine break out by Type, by Application?

Global Haemophilus Parasuis Bivalent Vaccine Market Scope

Report AttributeDetails
Market Size (Start Year)USD XX Million
Market Size (End Year)USD XX Million
Compound Annual Growth Rate (CAGR)USD XX Million
Forecast PeriodUSD XX Million
Base YearUSD XX Million
Historical DataUSD XX Million
Key PlayersUSD XX Million

REPORT COVERAGE

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

SEGMENT COVERED

By component, deployment, organization size, application, and industry.

REGIONAL SCOPE

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

COUNTRY SCOPE

Includes key countries across all major regions.


📘 Frequently Asked Questions

1. What is the market size of Global Global Haemophilus Parasuis Bivalent Vaccine Market?

Answer: The global Haemophilus Parasuis Bivalent Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

2. Which regions are analyzed in the Global Global Haemophilus Parasuis Bivalent Vaccine Market report?

Answer: The Global Global Haemophilus Parasuis Bivalent Vaccine Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.

3. What methodology is used for forecasting of Global Global Haemophilus Parasuis Bivalent Vaccine Market?

Answer: The Global Global Haemophilus Parasuis Bivalent Vaccine Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.

4. Are emerging markets analyzed separately in the Global Global Haemophilus Parasuis Bivalent Vaccine Market?

Answer: Yes, the Global Global Haemophilus Parasuis Bivalent Vaccine Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.

5. Does the report include competitive benchmarking of Global Global Haemophilus Parasuis Bivalent Vaccine Market?

Answer: Yes, Global Global Haemophilus Parasuis Bivalent Vaccine Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.

6. Can I access country-level data within the Global Global Haemophilus Parasuis Bivalent Vaccine Market report?

Answer: Yes, Global Global Haemophilus Parasuis Bivalent Vaccine Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.

7. Can I get customized insights or data from the Global Global Haemophilus Parasuis Bivalent Vaccine Market report?

Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.

Secure payment methods

🔐 Secure Payment Guaranteed

Safe checkout with trusted global payment methods.

🌟 Why Choose Infinity Market Research?

At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.

In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.

Here why global brands, startups, and decision-makers choose us:

Industry-Centric Expertise

With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.

Custom Research, Not Cookie-Cutter Reports

Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.

Data You Can Trust

Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.

Client-Centric Approach

Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.

📄 Available License Types

👤 Single User
$3660
👥 Multi User
$5490
🏢 Enterprise User
$7320
Buy Now
Secure payment methods

Recent Reports

Global Wearable Massager Market

Global Wearable Massager market size is predicted to grow from US$ 1436 million in 2025 to US$ 2683 million in 2031; it is expected to grow at a CAGR of 11.0% from 2025 to 2031.

Global Dog Pepper Spray Market

Global Dog Pepper Spray market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.